Hepatic steatosis is common in patients with chronic hepatitis C (CHC) and is reported to be a risk factor for progression of fibrosis. The aims of this study were to evaluate the interactions between hepatic steatosis and fibrosis in a well-defined cohort of patients with CHC. The computerized path
Progression of fibrosis in advanced chronic hepatitis C: Evaluation by morphometric image analysis
β Scribed by Zachary D. Goodman; Robert L. Becker Jr.; Paul J. Pockros; Nezam H. Afdhal
- Publisher
- John Wiley and Sons
- Year
- 2007
- Tongue
- English
- Weight
- 467 KB
- Volume
- 45
- Category
- Article
- ISSN
- 0270-9139
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
atitis activity index scoring system 14 and others, [15][16][17] have To clarify the characteristics of fibrosis developed in been used in the assessment of the degree of fibrosis, howthe process from chronic hepatitis C to cirrhosis, a morever, these methods cannot completely avoid the observer's p
## Abstract Although progression of fibrosis in the chronic hepatitis C depends on environmental, viral, and host factors, genetic polymorphisms have been associated recently with this progression, including the expression of integrins, adhesion proteins. Some integrins expressed on the platelet me
Cannabinoids present in Cannabis sativa (marijuana) exert biological effects via cannabinoid receptors CB1 and CB2. We recently demonstrated that CB1 and CB2 receptors regulate progression of experimental liver fibrosis. We therefore investigated the impact of cannabis smoking on fibrosis progressio
Patients infected with HIV-1 who are heterozygous at HLA class I loci present greater variety of antigenic peptides to CD8+ cytotoxic T lymphocytes, slowing progression to AIDS. A similar broad immune response in chronic hepatitis C (CHC) infection could result in greater hepatic injury. Although sp